You are here
Humanized Mouse and Rat Model Market Analysis by Key Manufacturers, Type, Applications and Forecast to 2022
The Humanized Mouse and Rat Model Market is projected to reach USD 128.9 Million, at a CAGR of 9.9% during the forecast period.
The Research Study on Humanized Mouse and Rat Model Market, By Considering useful aspects like; Application, End Users, Type- Global Future Forecast till 2022, published by MarketsandMarkets™, the report studies the global Humanized Mouse and Rat Model market over the forecast period to 2022.
The cell-based humanized mouse models segment is further categorized into CD34, PBMC, and BLT humanized mouse models. In 2017, the CD34 models segment commanded the largest share of the cell-based humanized mouse models market and is expected to grow at the highest CAGR during the forecast period. CD34 mouse models are used as in vivo platforms for analyzing the safety and effectiveness of potential new drugs that can modulate the immune system. They are used for long-term studies in the fields of immuno-oncology, infectious disease, and graft versus host disease. Thus, the growing application areas of CD34 models are expected to trigger the demand for these models in the coming years.
Humanized Mouse and Rat Model Market
Objectives of the Study:
- To define, describe, and forecast the global humanized mouse and rat models’ market on the basis of type, application, end user, and region
- To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and industry-specific challenges)
- To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
For any queries Speak to our Analyst:
The Humanized Mouse and Rat Model market is fragmented with the presence of emerging players;
The major market players in the humanized mouse models market include The Jackson Laboratory (US), Taconic Biosciences, Inc. (US), Horizon Discovery Group plc (UK), genOway, S.A. (France), Charles River Laboratories (US), Harbour Antibodies BV (China), Hera BioLabs (US), Vitalstar Biotechnology Co., Ltd. (China), inGenious Targeting Laboratory (US), AXENIS S.A.S (France), Crown Bioscience, Inc. (US), Transgenic, Inc. (Japan), and Champions Oncology, Inc. (US). The major players in the humanized rat models market include Horizon Discovery Group plc (UK), Hera BioLabs (US), and Yecuris Corporation (US)…..Read More
Request a Sample Copy of “Humanized Mouse and Rat Model Market” Consist 94 tables and 42 figures spread over 189 pages and in-depth TOC: https://www.marketsandmarkets.com/requestsample.asp?id=131763955
Humanized Mouse and Rat Model Market, by Type;
- Genetic Humanized Mouse Models
- Cell-based Humanized Mouse Models
- Humanized Mouse Models
Humanized Mouse and Rat Model Market, by End User;
- Pharmaceutical & Biotechnology Companies
- Contract Research Organizations
- Academic & Research Institutions
Humanized Mouse and Rat Model Market, by Application;
- Immunology and Infectious Diseases
Humanized Mouse and Rat Model Market, by Region;
· North America (US, Canada)
· Europe (UK, Germany, Others)
· Rest of the World
Major Key Points from Table of Content:
· Research Methodology
· Humanized Mouse and Rat Model Market, By Type
· Humanized Mouse and Rat Model Market, By Application
· Competitive Landscape
· Company Profiles
Download PDF Brochure:
Mr. Shelly Singh
630 Dundee Road
Northbrook, IL 60062
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model — GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, “RT” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.